Biomiicron

Chennai, India Founded: 1998 • Age: 28 yrs
Develops and produces pharmaceutical drugs for various medical categories including antiviral and pediatric care.

About Biomiicron

Biomiicron is a Healthcare company based in Chennai (India) founded in 1998. It develops and produces pharmaceutical drugs for various medical categories including antiviral and pediatric care. It operates on a B2B model. The company has 108 employees. Its Indian entity Biomiicron Pharma India Private Limited reported revenue of ₹10.49 Cr. Biomiicron offers products and services including Windose Tablet, Windose Syrup, Char-Sim, Orovit Active, and Hi-Q. Its focus areas include Health, Pharmaceuticals, Nutraceuticals and Health Supplements. Similar companies include Entero Healthcare, Keimed and Sandor Medicaids; 3 of its 3 listed similar companies have raised funding.

Company details

Biomiicron Pharma is a pharmaceutical company based in Chennai, India, specializing in developing and manufacturing a wide range of health products. It offers items such as antiviral tablets, syrups for gastroenterology, gynecological treatments, and pediatric solutions through its manufacturing plants. The company emphasizes quality management and research to serve healthcare needs, focusing on categories like pain management and respiratory care.

Key Metrics
  • Annual Revenue
    ₹10.49 Cr

    FY 2024 · -1% YoY

  • Net Loss
    -₹72,690

    FY 2024 · 0% margin

  • EBITDA
    ₹22.7 Lakh

    FY 2024 · 2% margin

  • Employee Count
    108

Products & Services of Biomiicron

Biomiicron offers a comprehensive portfolio of products and services, including Windose Tablet, Windose Syrup, Char-Sim, Orovit Active, and Hi-Q.

Windose Tablet
AntiViral

Tablet for treating viral infections and supporting immune health.

Windose Syrup
AntiViral

Syrup formulation for antiviral care in patients.

Char-Sim
Gastroenterology

Product for gastrointestinal relief and digestive support.

Orovit Active
Gynecology

Supplement for gynecological health and wellness needs.

Hi-Q
Infertility

Treatment aid for infertility issues and reproductive care.

Toxigon
Intensive Care

Medication for intensive care and toxin management.

Orovit Tablet
Nutraceuticals

Nutritional tablet for general health enhancement.

IFPAYNS GEL
Pain Management

Topical gel for pain relief and inflammation control.

Kidis’on
Pediatric Care

Preparation for pediatric health and child treatment.

Cetrid-O.D
Respiratory

Product for respiratory relief and symptom management.

Apps and channels of Biomiicron

its YouTube channel biomiicron pharma has 83 subscribers and 5 videos.

biomiicron pharma
YouTube 83 subscribers 5 videos Science & Technology
Open channel

Videos from Biomiicron

The most watched videos on Biomiicron's YouTube channel, biomiicron pharma (83 subscribers). Click a video to play it here.

Preparation of kidison
3.6K views
WINDOSE Tablet (Anti-Viral ) Dosage ,Use ,MOA ,Side effect by Dr Mrs Geetha G Hegde
1.5K views
Dr Shared his Valuable opinion about WINDOSE TABLET ANTIVIRAL #Andrographolide #Kalmegh
847 views
Happy Doctors Day #covidwarriors #HeroesOfTheFrontline #NationalDoctorsDay
181 views

More on biomiicron pharma.

Board of directors of Biomiicron Pharma India Private Limited (Biomiicron)

Biomiicron Pharma India Private Limited is the primary company behind Biomiicron. The board of Biomiicron Pharma India Private Limited currently have 2 directors; the longest-serving is Suresh Kumar, appointed in 2012.

DirectorDesignationAppointedTenureEntity
Suresh Kumar
DIN 02231888
Director28 Jun 201214 yrs 4 moBiomiicron Pharma India Private Limited
Ketchaani Rajan Makesh
DIN 01380057
Director28 Jun 201214 yrs 4 moBiomiicron Pharma India Private Limited

Financials of Biomiicron

Figures of Biomiicron Pharma India Private Limited, the primary company behind Biomiicron, for FY 2024. Revenue was ₹10.49 Cr (-1% year on year). Net loss was -₹72,690 (0% margin). EBITDA was ₹22.7 Lakh (2% margin). Revenue has grown at a compounded annual rate of +7% over three years and +3% over five years.

  • ₹10.49 CrRevenue · FY 2024 · -1% YoY
  • -₹72,690Net loss · 0% margin
  • ₹22.7 LakhEBITDA · 2% margin
  • ₹1 LakhPaid-up capital
  • 108Employees (provident fund records)
  • +7%Revenue CAGR, 3 years
  • +3%Revenue CAGR, 5 years

Balance sheet, profit and loss, cash flow and ratios of Biomiicron Pharma India Private Limited are on its company page.

Premium access

Detailed financial statements for Biomiicron

Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.

  • Statement rows
  • Financial ratios
  • Five-year trends
  • Downloads

Verified entity values are shown only after access is granted.

Similar companies to Biomiicron

Biomiicron has 3 listed similar companies in our database, 3 of them funded. They include Entero Healthcare, Keimed and Sandor Medicaids.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
enterohealthcare.com2018Mumbai, India$59.67M817
India's leading healthcare products distribution platform
keimed.com2000Hyderabad, India$16.62M588
Temperature-sensitive medicines are distributed via cold chain logistics by Keimed.
sandor.co.in1995Hyderabad, India$8.98M161
Provider of medical equipment, devices, and drugs distribution services
Premium access

Detailed similar companies of Biomiicron

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Top companies in Nutraceutical & Food-as-Medicine Platforms

3 companies that operate in the same segment as Biomiicron (Nutraceutical & Food-as-Medicine Platforms) in India, ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Ayurvedic healthcare and nutritional products are provided by Kapiva.
2016Bengaluru, Karnataka, IndiaUSD 77.85 MUSD 55.41 M362
Nutritional supplements for multiple health ailments are developed.
2005Mumbai, Maharashtra, IndiaUSD 1.55 M
Nutritional food and health supplements are provided by OZiva.
2010Mumbai, Maharashtra, IndiaUSD 17.32 MUSD 56.21 M144
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • ✓
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • ✓
    Full access to every database India & global coverage, advanced filters and rich profile details
  • ✓
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about Biomiicron

Biomiicron was founded in 1998.

Biomiicron is headquartered in Chennai, India. It is registered at Chennai, Tamil Nadu, India.

Biomiicron has 108 employees.

The primary company behind Biomiicron, Biomiicron Pharma India Private Limited, reported revenue of ₹10.49 Cr for FY 2024, down 1% year on year.

Biomiicron Pharma is a pharmaceutical company based in Chennai, India, specializing in developing and manufacturing a wide range of health products. It offers items such as antiviral tablets, syrups for gastroenterology, gynecological treatments, and pediatric solutions through its manufacturing plants. The company emphasizes quality management and research to serve healthcare needs, focusing on categories like pain management and respiratory care.

Biomiicron's top competitors include Entero Healthcare, Keimed and Sandor Medicaids.

Biomiicron offers Windose Tablet, Windose Syrup, Char-Sim, Orovit Active, and 6 more products and services.

Biomiicron operates through Biomiicron Pharma India Private Limited.

The legal entities of Biomiicron currently have 2 directors, including Suresh Kumar, Ketchaani Rajan Makesh.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available